Mechanisms and Models of SPTAN1 Epileptic Encephalopathy
Mechanisms and Models of SPTAN1 Epileptic Encephalopathy
批准号:
10053733
负责人:
Yu Wang
金额:
$19.01万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-01 至 2021-11-30
关键词:
ActinsAcuteAdhesionsAnimalsAxonBindingBrainC-terminalCell CommunicationCell Culture TechniquesCell modelCellsClustered Regularly Interspaced Short Palindromic RepeatsComplexCytoskeletonDNADNA Sequence AlterationDataDevelopmentDevelopment PlansDevelopmental Delay DisordersDiseaseDisease modelDisinhibitionDoctor of MedicineDoctor of PhilosophyDominant-Negative MutationDyskinetic syndromeElectrophysiology (science)ElectroporationElementsEmbryoEpilepsyEpileptogenesisExcitatory SynapseFibroblastsFoundationsFunctional disorderFundingFutureGenesGeneticGenetic studyGoalsGrantHeterodimerizationHumanImpaired cognitionIn VitroInfantInfantile spasmsInhibitory SynapseIntellectual functioning disabilityKnowledgeLaboratoriesLeadLightLinkManuscriptsMechanical StressMediatingMedicineMembraneMethodsModelingMolecularMusMutateMutationNatureNeurologistNeurologyNeuronsNeurosciencesPaperPathogenicityPatientsPeriodicityPhysiciansPlayProcessProsencephalonProteinsPublishingRattusReporterResearchRoleScientistSeizuresSideSliceSpectrinStructureStudy modelsSystemTestingTherapeutic StudiesTrainingTraining ActivityViralViral VectorWorkWritingbasebeta Spectrincareercareer developmentchildhood epilepsyde novo mutationdrug use screeningearly childhoodepileptic encephalopathiesexcitatory neurongenetic manipulationgenome editinghippocampal pyramidal neuronhuman modelin uteroin vitro Modelin vivoin vivo Modelinduced pluripotent stem cellinfancyinhibitory neuroninnovationinsightmigrationmutantnervous system disorderneurodevelopmentneuron developmentnoveloverexpressionpostsynapticskillsstem cell biologystem cell modelsuccesssynaptogenesistool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract/Project Summary
Applicant: Dr. Wang holds M.D. and Ph.D. degrees, and has completed specialized training in both neurology
and epilepsy. During his Ph.D. work, he published 9 manuscripts including three first-author papers in
Neuroscience and one second-author paper in Nature Medicine. During his neurology training, he conducted a
genetic study on familial paroxysmal kinesigenic dyskinesia and co-authored one paper (under review).
Research Plan: Defining how genetic mutations that cause infantile epileptic encephalopthies (IEEs) disrupt
neurodevelopment should provide conceptual insights broadly relevant to understanding brain development
and epilepsy mechanisms. Using CRISPR genome editing methods, in utero electroporation (IUE) and human
induced pluripotent stem cell (iPSC) cultures, I propose to study the function of SPTAN1, a recently identified
gene (encoding alpha II-spectrin) mutated in patients presenting with IEE. My preliminary data show that
SPTAN1 regulates critical aspects of neuronal development, including axonal initial segment (AIS) formation,
process outgrowth and clustering of postsynaptic proteins. My central hypotheses are that SPTAN1 plays
critical roles in neurodevelopment through regulating neuronal migration, process outgrowth and synapse
formation, and that disinhibition of excitatory neurons leads to seizures in SPTAN1 IEE. I propose two specific
aims to test my hypotheses: 1) To determine how deleting Sptan1 or overexpressing mutant SPTAN1 in
cortical pyramidal neurons alters brain development and network excitability; and 2) To establish how
mutations in SPTAN1 influence excitatory and inhibitory cortical neuron development and excitability
using patient-derived iPSCs. This innovative proposal combines a rat IUE in vivo model (Aim 1) and an in
vitro model with patient-derived neurons (Aim 2). These models will be invaluable tools to study brain
development, and will also serve as an entry point for future drug screening using patient-derived neurons.
Immediate and long-term career goals: My career goal is to become an independent physician-scientist
focusing on brain development and genetic epilepsies. My long-term goal is to understand how genetic
mutations alter neurodevelopment and ultimately lead to seizures and intellectual disability. My short-term goal
is to obtain knowledge (e.g., stem cell biology and electrophysiology) and skills (e.g., iPSC cultures, viral-
based gene manipulation) in neuroscience to fill the gaps of my previous training in order to augment my
chances of success as an independently funded neuroscientist. The key elements of this research career
development plan are 5 key training goals. They are stem cell biology, electrophysiology principles, viral vector
based genetic manipulation, grant writing and laboratory management skills.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/ana.25272
发表时间:
2018-07
期刊:
Annals of neurology
影响因子:
11.2
作者:
[Hu S, Knowlton RC, Watson BO, Glanowska KM, Murphy GG, Parent JM, Wang Y]
通讯作者:
Wang Y
DOI:
10.1016/j.neulet.2021.136351
发表时间:
2022-01-01
期刊:
Neuroscience letters
影响因子:
2.5
作者:
[Hu S, Kao HY, Yang T, Wang Y]
通讯作者:
Wang Y
DOI:
10.1242/dev.195586
发表时间:
2021-01-20
期刊:
Development (Cambridge, England)
影响因子:
--
作者:
[Hu S, Yang T, Wang Y]
通讯作者:
Wang Y
Leaky Blood-Brain Barrier: A Double Whammy for the Brain.
血脑屏障渗漏:对大脑的双重打击。
DOI:
10.1177/1535759720917920
发表时间:
2020
期刊:
Epilepsy currents
影响因子:
3.6
作者:
[Wang,Yu]
通讯作者:
Wang,Yu
Cell Systems to Pre-Clinical Models
-
批准号:10670374
-
项目类别:
-
资助金额:$57.78万
-
财政年份:2020
-
负责人:Yu Wang
-
依托单位:
Cell Systems to Pre-Clinical Models
-
批准号:10455559
-
项目类别:
-
资助金额:$58.09万
-
财政年份:2020
-
负责人:Yu Wang
-
依托单位:
Cell Systems to Pre-Clinical Models
-
批准号:10265443
-
项目类别:
-
资助金额:$57.43万
-
财政年份:2020
-
负责人:Yu Wang
-
依托单位:
Cortical development and pathogenesis in DEPDC5-related epilepsies
-
批准号:10624357
-
项目类别:
-
资助金额:$42.2万
-
财政年份:2019
-
负责人:Yu Wang
-
依托单位:
Cortical development and pathogenesis in DEPDC5-related epilepsies
-
批准号:10409774
-
项目类别:
-
资助金额:$42.2万
-
财政年份:2019
-
负责人:Yu Wang
-
依托单位:
Cortical development and pathogenesis in DEPDC5-related epilepsies
-
批准号:10164883
-
项目类别:
-
资助金额:$40.86万
-
财政年份:2019
-
负责人:Yu Wang
-
依托单位:
Cortical development and pathogenesis in DEPDC5-related epilepsies
-
批准号:10016841
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2019
-
负责人:Yu Wang
-
依托单位:
海外基金